Relmada Therapeutics (RLMD)
6.73
+0.13 (1.97%)
Upcoming Events
Latest Headlines
Form S-8 RELMADA THERAPEUTICS,
June 18, 2026 4:06 PM - SEC Filing
H.C. Wainwright Starts Relmada Therapeutics Inc (RLMD) at Buy, PT $12
June 18, 2026 5:59 AM - StreetInsider
Relmada appoints Michael Quirk as senior advisor for sepranolone program
June 11, 2026 7:02 AM - StreetInsider
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
June 11, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Venrock Healthcare Capital Partners III, L.P.
June 9, 2026 8:04 PM - SEC Filing
Form 8-K RELMADA THERAPEUTICS, For: May 27
May 28, 2026 5:50 PM - SEC Filing
Relmada Therapeutics (RLMD) to Present at the Jefferies Global Healthcare Conference
May 28, 2026 7:04 AM - StreetInsider
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
May 28, 2026 7:00 AM - Globe NewsWire
Relmada Therapeutics (RLMD) files mixed shelf
May 13, 2026 4:59 PM - StreetInsider
Form S-3ASR RELMADA THERAPEUTICS,
May 13, 2026 4:53 PM - SEC Filing
Form SCHEDULE 13G/A RELMADA THERAPEUTICS, Filed by: Adage Capital Management, L.P.
May 13, 2026 9:15 AM - SEC Filing
Form 8-K RELMADA THERAPEUTICS, For: May 12
May 12, 2026 5:01 PM - SEC Filing
Relmada Therapeutics (RLMD) Misses Q1 EPS by 1c
May 12, 2026 4:08 PM - StreetInsider
Form 10-Q RELMADA THERAPEUTICS, For: Mar 31
May 12, 2026 4:07 PM - SEC Filing
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026 4:05 PM - Globe NewsWire
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
May 6, 2026 7:00 AM - Globe NewsWire
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
May 5, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Commodore Capital LP
May 4, 2026 4:26 PM - SEC Filing
Form DEFA14A RELMADA THERAPEUTICS,
April 17, 2026 4:32 PM - SEC Filing
Form DEF 14A RELMADA THERAPEUTICS, For: May 27
April 17, 2026 4:31 PM - SEC Filing
Form EFFECT RELMADA THERAPEUTICS,
April 10, 2026 6:03 AM - SEC Filing
Form 424B3 RELMADA THERAPEUTICS,
April 9, 2026 4:21 PM - SEC Filing
Mizuho Reiterates Outperform Rating on Relmada Therapeutics Inc (RLMD)
April 8, 2026 6:39 AM - StreetInsider
Form PRE 14A RELMADA THERAPEUTICS, For: Apr 06
April 6, 2026 4:35 PM - SEC Filing
Form S-3 RELMADA THERAPEUTICS,
April 3, 2026 4:31 PM - SEC Filing
Piper Sandler Starts Relmada Therapeutics Inc (RLMD) at Overweight
March 24, 2026 3:59 AM - StreetInsider
Full Article List
